At the Molecular Targets Meeting in Boston, Massachusetts, sessions highlighted the diverse applications of AACR Project GENIE data, including leveraging clinico-genomic information for research (Ken Kehl, DFCI), examining off-label targeted therapy utilization within GENIE BPC datasets (Jeremy Warner, Brown), and identifying novel drug targets through GENIE data analysis (Phillip Beer, Step Pharma).
